Authors/Disclosures
|
Andrew D. Goodman, MD, FAAN
(University of Rochester Dept. Neurology)
|
Dr. Goodman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Swan Bio. Dr. Goodman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Goodman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Goodman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lilly. Dr. Goodman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Goodman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Dr. Goodman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for IMCYSE. Dr. Goodman has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Pfizer. The institution of Dr. Goodman has received research support from Atara. The institution of Dr. Goodman has received research support from Genzyme. The institution of Dr. Goodman has received research support from EMD-Serono. |
|
Andrew Blight, PhD
(Acorda Therapeutics, Inc)
|
No disclosure on file |
|
Jerome Lisk, MD, MBA, MS, FAAN
(MD Neurology)
|
The institution of Dr. Lisk has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for TEVA. The institution of Dr. Lisk has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amneal PHarmaceuticals. The institution of Dr. Lisk has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for ADAMAS. Dr. Lisk has received intellectual property interests from a discovery or technology relating to health care. |
|
|
No disclosure on file |